Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
565-04-001 ISMRM Abstract

Cluster-Specific Radiomics Predicting Induction Chemotherapy Response in Nasopharyngeal Carcinoma

Primary: Neuro - Head & Neck/ENT
Secondary: Analysis Methods - Radiomics
565-04-001 · Neuroradiomics · Wednesday, 13 May, 2:35 PM–3:30 PM · Digital Posters Row F
Keywords: Magnetic resonance imaging Nasopharyngeal carcinoma Induction chemotherapy Cluster-based radiomics Tumor burden reduction
Accepted
Zhenhuan Huang 1, Zhaoxue Tu2, Peng Wu3, Lihang Cao1, Jing Qiu1, Qikui You1, Dandan Lin1, Tingyu Yu1, Hui Ma4, Yueming Li4,5,6
1Department of Radiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China
2Department of Orthopedics, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China
3Philips Healthcare, Guangzhou, China
4Department of Radiology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China
5Key Laboratory of Radiation Biology of Fujian higher education institutions, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China
6Department of Radiology, National Regional Medical Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China
Presenting Author: Zhenhuan Huang

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Yuan J, Wu M, Qiu L, Xu W, Fei Y, Zhu Y et al. Tumor habitat-based MRI features assessing early response in locally advanced nasopharyngeal carcinoma. Oral Oncol 2024;158:106980. PMID: 39151333 [pmid]
2. Zeng YY, Xiang ZZ, He T, Liu F, Shao BF, Yan RN et al. The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma. Oral Oncol 2020;111:104924. PMID: 32736209 [pmid]
3. Tan HQ, Cai J, Tay SH, Sim AYL, Huang L, Chua MLK et al. Cluster-based radiomics reveal spatial heterogeneity of bevacizumab response for treatment of radiotherapy-induced cerebral necrosis. Comput Struct Biotechnol J 2024;23:43-51. PMID: 38125298 [pmid]
4. Lin M, Zhang XL, You R, Liu YP, Cai HM, Liu LZ et al. Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance. Nat Commun 2023;14:610. PMID: 36739462 [pmid]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/565-04-001